Davis Polk partners David Bauer and Matt Bacal, counsel Samantha Lefland and law clerk Ted Talas authored “Artificial intelligence in drug development” in the Legal 500: Life Sciences...
Webinar
1.0 CA - General; NY - Professional Practice / Practice Management
Davis Polk is hosting a series of webinars focused on legal considerations for life sciences and healthcare companies. In this installment, senior lawyers discuss considerations and strat...
On February 12, 2024, the United States Patent and Trademark Office issued inventorship guidance for AI-assisted inventions. The guidance follows caselaw establishing that an AI system c...
Davis Polk partner David Bauer and counsel Samantha Lefland authored “Strategic considerations in life sciences partnering” in Financier Worldwide. In the article, the authors discuss...
The recent rise of consumer and market interest in generative artificial intelligence (GAI) tools has spurred growing interest in GAI assets from strategic acquirers and private equity in...
Webinar
1.0 NY - Professional Practice / Practice Management
Davis Polk is pleased to host a series of webinars over the coming months focused on legal considerations for life sciences companies. In this first installment, senior members of the Dav...
Below is our latest report on developments in IP, data privacy and cybersecurity law. In this issue, we discuss the EU’s Unified Patent Court, a pending copyright case regarding works cre...
Below is our latest report on developments in IP, data privacy and cybersecurity law. In this issue, we discuss, among other things, a variety of recent IP-related court decisions as well...
The Supreme Court yesterday found the administrative patent judges of the Patent Trial and Appeal Board to be unconstitutionally appointed but fashioned a tailored remedy by making their ...
On April 5, 2021, the U.S. Supreme Court issued a long-awaited decision in Google LLC v. Oracle America, Inc., holding that Google’s copying of certain portions of Oracle’s Java SE AP...
